Immunotherapy - Checkpoint Inhibitor, Targeted Immunotherapy Drugs
Explore immunotherapy and checkpoint inhibitors in cancer treatment, focusing on melanoma and lung cancer. Learn about biology, clinical trials, and toxicity management.
Understanding Cancer and Novel Treatment Approaches
Insightful discussion on cancer understanding and innovative treatment approaches, offering fresh perspectives on a complex medical challenge.
Management of Refractory Non-Hodgkin Lymphoma - Lecture 8
Explore effective salvage therapies for refractory non-Hodgkin lymphoma, including biological agents, autologous stem cell transplants, and CAR-T therapy for low and high-grade lymphomas.
Side Effects of Cancer Treatment
Comprehensive overview of cancer treatment side effects, including management strategies for common issues like mucositis, neutropenia, and cardiac toxicity. Covers newer therapies and psychosocial impacts.
Precision Dosing of Antibody Therapeutics: PET Imaging for Quantifying Activity in Tumors
Explore novel PET imaging techniques for quantifying therapeutic antibody activity in tumors, focusing on PD-L1 imaging agents and dose optimization strategies.
Imaging Therapeutic Immune Cells
Explore imaging techniques for therapeutic immune cells like CAR-T, enhancing understanding of their behavior and effectiveness in treatment.
Quantifying CAR T Cells Activity Against AML - Model Selection Based on In Vitro Cytolytic Assays
Explore quantitative modeling of CAR T cell activity against AML through in vitro cytolytic assays, enhancing understanding of immunotherapy effectiveness.
Multivalent RNA CAR-T Cell for Malignant Glioma
Explore innovative RNA CAR-T cell therapy for glioblastoma, addressing tumor heterogeneity through a multivalent approach. Learn about the development, testing, and potential of this promising treatment strategy.
Identification of Tumor-Reactive T Cell Receptors Through Functional Single Cell Interaction Analysis for Personalized T Cell Therapy
Explore innovative techniques for identifying tumor-reactive T cell receptors using single-cell analysis, advancing personalized cancer immunotherapy approaches for multiple myeloma patients.
CD3ζ as a Novel Integration Site for Reprogramming Immune Cells with Chimeric Antigen Receptors
Explore CD3ζ as a novel integration site for reprogramming immune cells with Chimeric Antigen Receptors. Learn about advancements in CAR-T therapies, challenges in current approaches, and potential solutions for improved accessibility and efficacy.
The Next Wave of Immunotherapy and Cancer Treatments
Expert panel explores cutting-edge immunotherapy advancements for cancer treatment, including mRNA vaccines, TIL cell therapy, and CAR-T approaches, discussing implications for patients, industry, and future cancer care.
Engineering Patient-Derived Tumoroids to Enable High-Throughput Screening for Immuno-Oncology
Explore patient-derived tumoroids as cost-effective cancer immunotherapy research models and learn about a proof-of-concept screening platform for validating NK cell cytotoxic activity.
Optimizing CAR Structures to Enhance Efficacy in Solid Tumors - Moving from Linear to Lateral Architectures
Explore advanced CAR T-cell therapy strategies for solid tumors, focusing on lateral architectures to overcome efficacy challenges in non-hematological cancers.
Tertiary Lymphoid Structures in Immunotherapy: Functions and Potential
Explore the role of tertiary lymphoid structures in tumor immunity, their correlation with improved prognosis, and their impact on immunotherapy response through in-depth spatial imaging analysis.
Cytokine Armored CAR NK Cell Therapy for Advanced Ovarian Cancer
Explore innovative CAR NK cell therapy for ovarian cancer using non-viral transposon engineering and CRISPR/Cas9 editing. Learn about advancements in immunotherapy and potential applications in solid tumors.
Monitoring of Circulating CAR T Cells
Explore CAR T cell monitoring techniques for successful treatment outcomes. Learn about critical reagents, detection strategies, and flow cytometry assays from expert researchers.
Catapult Your Cell Therapy Research Into the Clinic: CAR NK Cells and Tregs
Explore solutions to advance CAR NK cell and Treg-based therapies from research to clinical applications. Discover products, tools, and services to move your projects forward.
Translating B Cell Epitope Peptide Based Cancer Vaccines to the Clinic - Immunotherapies
Explore novel cancer immunotherapies using B cell epitope peptide vaccines, focusing on PD-L1 and HER-2 inhibitors for improved efficacy and reduced toxicity in clinical applications.
Selective Depletion of CD45RA Expressing Cells to Enrich Antigen-Specific T-Cells for Immunotherapy
Explore techniques for enriching antigen-specific T-cells through selective depletion of CD45RA expressing cells, enhancing immunotherapy potential for virus-associated malignancies.
The Evolving Landscape of Lung Cancer Treatment
Explore advancements in lung cancer treatment, including targeted therapies and immunotherapy. Learn about genetic diagnostics, improved survival rates, and emerging strategies for patient care in this evolving field.
Development of a T Cell Engineering Platform for Fully Individualized Neoantigen-Specific TCR Therapy
Explore a high-throughput platform for identifying neoantigen-reactive TCRs, advancing personalized cancer immunotherapy through T cell engineering and adoptive transfer techniques.